A clinical study of the correlation between QOL and the effects of oral anti-diabetic drugs on newly treated patients with type2 diabetes

QOL study group for oral anti-diabetic agent0 个研究点目标入组 800 人开始时间: 2012年1月4日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Newly treated with any oral anti-diabetic drugs and inadequate glycemic control(HbA1c 6.5-9.0%[the JDS]/6.9-9.4%6.9-9.4%[the NGSP] in spite of diet and exercise therapy for over 4 weeks
•2)Age of 20<=, 80>
•3)Out patients of either gender
•4)Patients who agree to participate in the study, and who are able to start in 12 weeks

•1)type1 diabetes(CPR blood test and anti-GAD test is recommended)
•2)Taking any anti-diabetic drugs
•3)Severe ketosis, precoma, diabetic coma
•4)Hepatic dysfunction(ALT <= 3times the upper limit of normal)
•5)Gastrointestinal dysfunction as diarrhea or vomiting
•6)Severe infection, severe injury. Before and after accepting surgery
•7)Pregnant or suspected to be pregnant
•8)History of hypersensitivity to any component of testing drugs
•9)History of cancer or being treated for cancer
•10)Whom the doctor in charge decided not to be appropriate for this study on the point of medical reason

发起方

QOL study group for oral anti-diabetic agent